Request for Proposal

Pre-Clinical Studies of a Novel ER-Beta Agonist Small Molecule: WT-IV-012

The OSU Drug Development Institute (DDI) in collaboration with the College of Medicine and the Center for Clinical and Translational Sciences are working together to sponsor a pilot project to generate pre-clinical data with a novel, selective Estrogen receptor Beta (ERb or ESR2) agonist WT-IV-012. This effort seeks to identify between 5 to 15 worthwhile proposals to perform pre-clinical work with this compound focused on generating data that will be useful for eventual decisions relative to clinical application of this agent. Each proposal may request up to $50,000.

Deadline: Monday, September 17, 2018 at 5:00pm

View the full RFP here